leflunomide has been researched along with Anemia in 4 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Excerpt | Relevance | Reference |
---|---|---|
"To estimate the incidence of pancytopenia in patients taking leflunomide with or without methotrexate in Australia." | 7.74 | The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate. ( Calcino, LJ; Hill, RL; McEwen, J; Purcell, PM; Riley, CG, 2007) |
"Rheumatoid arthritis is a chronic disease of the joints, which causes joint pain and disability." | 5.48 | Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis. ( Colares, VLP; Fernandes, AMR; Fernandes, ES; Martins, MMRS; Mendes, SJF; Monteiro, CRAV; Muniz, TF; Pereira, DMS; Pereira, ICP; Silva, BLR; Sousa, NCF, 2018) |
"To estimate the incidence of pancytopenia in patients taking leflunomide with or without methotrexate in Australia." | 3.74 | The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate. ( Calcino, LJ; Hill, RL; McEwen, J; Purcell, PM; Riley, CG, 2007) |
"Rheumatoid arthritis is a chronic disease of the joints, which causes joint pain and disability." | 1.48 | Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis. ( Colares, VLP; Fernandes, AMR; Fernandes, ES; Martins, MMRS; Mendes, SJF; Monteiro, CRAV; Muniz, TF; Pereira, DMS; Pereira, ICP; Silva, BLR; Sousa, NCF, 2018) |
"The prednisone dose was reduced by a mean of 25% in these same 13 patients." | 1.31 | Experiences with leflunomide in solid organ transplantation. ( Brady, L; Chong, A; Huang, W; Jensik, S; Kottayil, A; Longstreth, J; Millis, M; Mital, D; Williams, JW, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pereira, ICP | 1 |
Sousa, NCF | 1 |
Pereira, DMS | 1 |
Mendes, SJF | 1 |
Muniz, TF | 1 |
Colares, VLP | 1 |
Silva, BLR | 1 |
Monteiro, CRAV | 1 |
Martins, MMRS | 1 |
Fernandes, AMR | 1 |
Fernandes, ES | 1 |
Wang, H | 1 |
Sun, L | 1 |
Tan, W | 1 |
McEwen, J | 1 |
Purcell, PM | 1 |
Hill, RL | 1 |
Calcino, LJ | 1 |
Riley, CG | 1 |
Williams, JW | 1 |
Mital, D | 1 |
Chong, A | 1 |
Kottayil, A | 1 |
Millis, M | 1 |
Longstreth, J | 1 |
Huang, W | 1 |
Brady, L | 1 |
Jensik, S | 1 |
4 other studies available for leflunomide and Anemia
Article | Year |
---|---|
Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis.
Topics: Adalimumab; Adult; Anemia; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; | 2018 |
Clinical features of children with pulmonary microscopic polyangiitis: report of 9 cases.
Topics: Adolescent; Anemia; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Child; Child, | 2015 |
The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; An | 2007 |
Experiences with leflunomide in solid organ transplantation.
Topics: Anemia; Calcineurin Inhibitors; Creatinine; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Tra | 2002 |